Abvc Biopharma Inc (ABVC) Stock Price, Quote & News

Company Profile

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II cl...

Industry: Biotechnology

Sector: Healthcare

Phone: 510 668 0881

Website: www.abvcpharma.com

Address:

44370 Old Warm Springs Boulevard, Fremont, United States

BigdollarMaker Sep. 8 at 4:35 PM

$ABVC $GORO

0 · Reply

BigdollarMaker Sep. 5 at 3:32 PM

$BB $ABVC $RITE Time to get a move on!!

0 · Reply

Gollum00 Sep. 4 at 6:15 PM

$ABVC Any news with the Aibtl IPO…….. they said summer of 25 of which is just about over.

0 · Reply

NVDAMillionaire Sep. 4 at 2:52 PM

$ABVC Outstanding article that hits the mark on ABVC's current state. So if you want to refresh your ABVC insights or learn about ABVC from scratch, this is a must read. https://beyondspx.com/quote/ABVC/abvc-biopharma-unearthing-value-in-plant-derived-therapies-and-strategic-asset-growth-nasdaq-abvc#analysis

0 · Reply

ProfitGainer Aug. 29 at 8:01 PM

$ABVC $450K Payment today. The big guys are playing games. Stay strong. https://finance.yahoo.com/news/abvc-biopharma-receives-450-000-113000145.html

0 · Reply

ProfitGainer Aug. 27 at 5:10 PM

$ABVC Another $230K Payment. https://finance.yahoo.com/news/biolite-inc-abvc-biopharma-subsidiary-062500225.html

0 · Reply

BigdollarMaker Aug. 25 at 3:23 PM

$ABVC weak hands, will lose in the end! Hold tight, our day is coming$$$

0 · Reply

ChartSwirl Aug. 23 at 4:31 AM

$ABVC ABVC BioPharma is a micro-cap biotech with multiple early-stage candidates and significant funding needs

0 · Reply

ProfitGainer Aug. 22 at 6:22 PM

$ABVC Another $100K licensing payment. https://finance.yahoo.com/news/abvc-biopharma-receives-100-000-113000467.html

0 · Reply

jacksparo Aug. 20 at 9:21 PM

$ICU $SLS I will update my plan about those two most likely by this coming weekend! $OCGN $VERU $ABVC I might share new plans for those via the email also! Let us see what will happen tomorrow in this market!

0 · Reply

ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners

Oct 22, 2024, 8:45 AM EDT - 11 months ago

ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners

Aug 15, 2024, 7:30 AM EDT - 1 year ago

ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements

Apr 18, 2024, 9:25 AM EDT - 1 year ago

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share

Apr 17, 2024, 9:00 AM EDT - 1 year ago

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M

Apr 10, 2024, 8:30 AM EDT - 1 year ago

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M

Mar 26, 2024, 8:30 AM EDT - 1 year ago

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M

Mar 19, 2024, 8:30 AM EDT - 1 year ago

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine

Mar 14, 2024, 9:30 AM EDT - 1 year ago

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update

Feb 15, 2024, 8:30 AM EST - 1 year ago

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues

Feb 12, 2024, 8:30 AM EST - 1 year ago

ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)

Feb 8, 2024, 9:17 AM EST - 1 year ago

ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share

Jan 3, 2024, 7:24 AM EST - 1 year ago

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees

Dec 7, 2023, 8:30 AM EST - 1 year ago

ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study

Nov 21, 2023, 8:30 AM EST - 1 year ago

ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market

Nov 16, 2023, 10:05 AM EST - 1 year ago

ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M

Nov 15, 2023, 9:00 AM EST - 1 year ago

ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results

Oct 26, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Entered Into a Term Sheet to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma at the Valuation of $667 Million

Oct 17, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Announces Completion of Subject Recruitment for Interim Analysis on ADHD Phase IIb Clinical Study

Oct 9, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Receives Taiwanese Patent for Its Treatment of Major Depressive Disorder (MDD)

Aug 23, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Provides Updates on ADHD Phase IIb Clinical Study

Aug 17, 2023, 9:19 AM EDT - 2 years ago

ABVC Executes Cooperation Agreement for Strategic Investments

Aug 10, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid Price Requirement

Aug 7, 2023, 8:30 AM EDT - 2 years ago

ABVC Corporate Update and CEO's Letter to Shareholders

Aug 3, 2023, 9:20 AM EDT - 2 years ago

ABVC Announces the Approval of the Plan for GMP Production Facilities of Vitargus by Taiwan Science Park Administration

Aug 1, 2023, 8:30 AM EDT - 2 years ago

ABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M and Royalties of 5-12% of Net Sales

Jul 31, 2023, 9:30 AM EDT - 2 years ago

ABVC BioPharma Announces Closing on $1.75 Million Registered Direct Offering

Jul 27, 2023, 9:22 AM EDT - 2 years ago

ABVC BioPharma Announces Pricing of $1.75 Million Registered Direct Offering

Jul 26, 2023, 8:30 AM EDT - 2 years ago

ABVC Signs Term Sheet to Acquire Real Estate Assets for Strategic Investments

Jul 24, 2023, 12:30 PM EDT - 2 years ago

ABVC BioPharma Announces Reverse Stock Split

Jul 6, 2023, 8:30 AM EDT - 2 years ago

The New CEO of ABVC BioPharma Takes Steps to Help Improve Cash Efficiency

Jun 26, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth

Jun 20, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Subsidiary BioKey Projects $1.0 Million Proceeds From Dietary Supplement Production

Jun 12, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma ADHD Phase II Part 2 Clinical Study First Subject Enrolled at UCSF

Jun 6, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Announces Collaboration With MerDury BioPharma for New Product Development and Commercialization

May 22, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Vitargus® Phase II Study Received Ethical Approval at Sydney Eye Hospital in Australia

Apr 10, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Provides ABV-1601 Update on Phase I Site Initiation Visit Conducted at Cedars-Sinai Medical Center (CSMC)

Apr 6, 2023, 8:30 AM EDT - 2 years ago

ABVC BioPharma Provides Vitargus Update on Phase II Site Initiation Visit Conducted at Ramathibodi Hospital in Thailand

Mar 31, 2023, 6:49 PM EDT - 2 years ago

ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results

Mar 20, 2023, 7:00 AM EDT - 2 years ago

ABVC BioPharma Provides Vitargus® Update on Phase II Site Initiation Visit Conducted at Srinagarind Hospital in Thailand

Mar 14, 2023, 7:00 AM EDT - 2 years ago

ABVC BioPharma Receives Registration Approval for Maitake Mushroom Dietary Supplement by the Taiwan Ministry of Health and Welfare

Feb 28, 2023, 8:30 AM EST - 2 years ago

ABVC BioPharma Provides 2023 Pipeline Update

Feb 23, 2023, 4:16 PM EST - 2 years ago

ABVC BioPharma Receives $3.175 Million Investment From The Lind Partners to Continue Clinical Trials

Feb 21, 2023, 8:30 AM EST - 2 years ago

ABVC BioPharma Receives Australian TGA Approval to Initiate Phase II Study of Vitargus®

Jan 19, 2023, 8:30 AM EST - 2 years ago

ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented at 2023 APSARD Conference

Jan 5, 2023, 8:30 AM EST - 2 years ago

FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment of Non-Small Cell Lung Cancer

Nov 17, 2022, 8:30 AM EST - 3 years ago

ABVC BioPharma Provides Vitargus® Update - Phase II Vitargus® Study Protocol Received Thai FDA Approval

Nov 14, 2022, 6:20 PM EST - 3 years ago

ABVC BioPharma Reports Third Quarter 2022 Financial and Operational Results

Nov 7, 2022, 8:30 AM EST - 3 years ago

ABVC BioPharma Receives Notice of Allowance from US Patent and Trademark Office for ABV-1504 Used to Treat Major Depressive Disorder (MDD)

Nov 2, 2022, 8:30 AM EDT - 3 years ago

Cedars-Sinai Medical Center Joins Phase I Clinical Study of ABVC BioPharma's Medication for Treating Depression in Cancer Patients

BigdollarMaker Sep. 8 at 4:35 PM

$ABVC $GORO

0 · Reply

BigdollarMaker Sep. 5 at 3:32 PM

$BB $ABVC $RITE Time to get a move on!!

0 · Reply

Gollum00 Sep. 4 at 6:15 PM

$ABVC Any news with the Aibtl IPO…….. they said summer of 25 of which is just about over.

0 · Reply

NVDAMillionaire Sep. 4 at 2:52 PM

0 · Reply

ProfitGainer Aug. 29 at 8:01 PM

$ABVC $450K Payment today. The big guys are playing games. Stay strong. https://finance.yahoo.com/news/abvc-biopharma-receives-450-000-113000145.html

0 · Reply

ProfitGainer Aug. 27 at 5:10 PM

$ABVC Another $230K Payment. https://finance.yahoo.com/news/biolite-inc-abvc-biopharma-subsidiary-062500225.html

0 · Reply

BigdollarMaker Aug. 25 at 3:23 PM

$ABVC weak hands, will lose in the end! Hold tight, our day is coming$$$

0 · Reply

ChartSwirl Aug. 23 at 4:31 AM

$ABVC ABVC BioPharma is a micro-cap biotech with multiple early-stage candidates and significant funding needs

0 · Reply

ProfitGainer Aug. 22 at 6:22 PM

$ABVC Another $100K licensing payment. https://finance.yahoo.com/news/abvc-biopharma-receives-100-000-113000467.html

0 · Reply

jacksparo Aug. 20 at 9:21 PM

0 · Reply

Syndr78 Aug. 19 at 8:56 PM

$ABVC Jumped in here at 2.94. Hoping the CFO firing starts to turn things around, soon

1 · Reply

BigdollarMaker Aug. 19 at 7:56 PM

$ABVC

0 · Reply

ProfitGainer Aug. 19 at 7:01 PM

$ABVC Still heavily shorted, but they will be screwed on any good news. https://www.iborrowdesk.com/report/abvc

0 · Reply

jacksparo Aug. 16 at 6:24 PM

$ABVC After I traded from below 1.20 to above 5 back in July. I am getting a new trade plan for it as I am seeing another bullish zone ahead! I shared this in my emails multiple times and all paid big!

0 · Reply

ProfitGainer Aug. 14 at 7:58 PM

$ABVC Nice earnings again showing strong growth.

1 · Reply

Gollum00 Aug. 14 at 1:16 PM

$ABVC did they announce today for their earnings yet?

1 · Reply

lostsailor0007 Aug. 12 at 2:40 AM

$ABVC Buy the PM dip. $ABVC still got some running to do, it's Strong! Low float at 15m and a 5.15% gain today overall. I'd still buy the dip. Earnings on 8-13-2025, right around the corner. Price Target at $15-$20, goin' long here. I'm in at $2.75. Let's hope she gets there, then rebounds. $3.00+.

0 · Reply

BigdollarMaker Aug. 11 at 4:53 PM

$ABVC It's going to get fun around here$$

0 · Reply

ProfitGainer Aug. 11 at 4:20 PM

$ABVC Earnings could be this week or next week, and it should be huge compared to last quarter.

0 · Reply

ProfitGainer Aug. 8 at 6:44 PM

$ABVC Make no sense why brokers don't post all the news going on. I guess Yahoo is the only reliable news source. https://finance.yahoo.com/news/biokey-stands-strategic-u-pharmaceutical-110000355.html

0 · Reply

Innoce Aug. 7 at 6:49 PM

$ABVC when should be the clinical results announcing? anyone?

1 · Reply

BigdollarMaker Aug. 7 at 5:05 PM

$ABVC Turn around your going the

1 · Reply

Market Cap	62.39M
Revenue (ttm)	510,000.00
Net Income (ttm)	-4.90M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-960.78%
Debt to Equity Ratio	0.01

Volume	58,400
Avg Vol	383,040
Day's Range	N/A - N/A
Shares Out	23.54M
Stochastic %K	33%
Beta	0.27
Analysts	Strong Buy
Price Target	$20.20